Drug firms finance Europe’s patient groups with multi-million donations

Pharmaceutical industry pours €110 million into advocacy organisations across the continent, Investigate Europe research reveals. Critics argue that funding threatens “independence” of the sector, claims that are rejected by groups.

Investigate Europe

'Revealed: #DrugFirms funding #UK patient groups that lobby for #NHS approval of #medicines

Observer investigation shows that majority of #Nice #DrugAppraisals involve groups financially linked to maker of #pharmaceuticals
https://www.theguardian.com/science/2023/jul/22/revealed-drug-firms-funding-uk-patient-groups-that-lobby-for-nhs-approval-of-medicines
#BigPharma #Corruption'

Revealed: drug firms funding UK patient groups that lobby for NHS approval of medicines

Observer investigation shows that majority of Nice drug appraisals involve groups financially linked to maker of pharmaceuticals

The Guardian